Education
About Us
Working with TipRanks
Follow Us
Henry Schein (HSIC)
NASDAQ:HSIC
HSIC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$63.67 - $82.49
Previous CloseN/A
Volume226.89K
Average Volume (3M)2.42M
Market Cap
$8.62B
Enterprise Value$13.64B
Total Cash (Recent Filing)$122.00M
Total Debt (Recent Filing)$2.87B
Price to Earnings (P/E)22.7
Beta0.44
Next Earnings
May 13, 2025EPS Estimate
1.14Last Dividend Ex-Date
Feb 08, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)3.05
Shares Outstanding124,176,780
10 Day Avg. Volume1,735,436
30 Day Avg. Volume2,415,628
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.68
Price to Cash Flow (P/CF)10.60
P/FCF Ratio9.00
Enterprise Value/Market Cap1.58
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.40
Enterprise Value/Ebitda13.92
Forecast
1Y Price Target
$80.27Price Target Upside15.68% Upside
Rating ConsensusHold
Number of Analyst Covering13
---
Henry Schein News
PremiumCompany Announcements
Henry Schein Announces Leadership Transition in 2025---
Bulls Say, Bears Say
Bulls Say
Board ExperienceThe KKR partners joining the HSIC Board of Directors bring additional Healthcare background / experience, which should also help with the strategic outlook.
Specialty Segment GrowthSpecialty segment growth was a bright spot in the quarter, with 4Q organic growth up 5% driven by strength across implants, biomaterial products, and endodontics.
Strategic InvestmentKKR's 12% investment in shares of HSIC is seen as positive for the company, as it shows confidence in the long-term outlook for HSIC beyond 2025.
Bears Say
Dental Market PerformanceThe core Dental/Medical distribution businesses remain soft, with no clear signs of improvement in the dental markets near-term.
Earnings GuidanceThe 2025 EPS guidance of $4.80-4.94 is below current Street view of $5.00.
Revenue ShortfallTotal revenue of $3.19 billion (+5.8% as reported) fell significantly short of the original expectation of $3.35 billion.
---
Ownership Overview
1.39% Insiders
29.47% Mutual Funds
34.67% Other Institutional Investors
9.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HSIC FAQ
What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest stock price was $63.67 and its highest was $82.49 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $8.62B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is May 13, 2025 which is in 50 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on Feb 25, 2025. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.204 by -$0.014.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein pays a Notavailable dividend of $17.219 which represents an annual dividend yield of N/A. See more information on Henry Schein dividends here
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 1.14.
How many shares outstanding does Henry Schein have?
Henry Schein has 124,176,780 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $1.19 in its last earnings report, missing expectations of $1.204. Following the earnings report the stock price went down -2.344%.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in HSIC
---
Henry Schein Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$80.27 (15.68% Upside)
$80.27 (15.68% Upside)
Blogger Sentiment
Bullish
HSIC Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 806.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $711.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.3%
Last 30 Days ▲ 16.7%
Last 30 Days ▲ 16.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.33%
12-Months-Change
Fundamentals
Return on Equity
11.07%
Trailing 12-Months
Asset Growth
-3.36%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
---
HSIC Company Deck
---
HSIC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong achievements in strategic goals and specialty product growth. However, challenges in the orthodontic segment, medical sales, and flat patient traffic tempered the positive outlook. The sentiment remains balanced with noteworthy strategic successes and operational hurdles.Read More>---
HSIC Revenue Breakdown
84.66% Global Distribution and Value-Added Services
10.37% Global Specialty Products
4.97% Global Technology
---
HSIC Stock 12 Month Forecast
Average Price Target
$80.27
▲(15.68% Upside)
Technical Analysis
Baxter International
―
Cardinal Health
―
McKesson
―
Omega Healthcare
―
Patterson Companies
―
Best Analysts Covering HSIC
1 Year
1 Year Success Rate
8/19 ratings generated profit
1 Year Average Return
-0.09%
reiterated a buy rating 18 days ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of -0.09% per trade.
---